Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (20)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Brosens, J.
Right arrow Articles by Brosens, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brosens, J.
Right arrow Articles by Brosens, I.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 19, No. 2, 352-356, February 2004
© 2004 European Society of Human Reproduction and Embryology

High endometrial aromatase P450 mRNA expression is associated with poor IVF outcome

Jan Brosens1, Hugo Verhoeven2, Rudi Campo3, Luca Gianaroli4, Stephan Gordts3, Johan Hazekamp5, Leif Hägglund6, Tonko Mardesic7, Eero Varila8, Josef Zech9 and Ivo Brosens3

1 Institute for Reproductive and Developmental Biology, Wolfson & Weston Research Centre for Family Health, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 ONN, UK, 2 FertiGen, Düsseldorf, Germany, 3 Leuven Institute for Fertility and Embryology, Leuven, Belgium, 4 Sismer, Bologna, Italy, 5 Volvat Medical Center, Oslo, Norway, 6 IVF-Kliniken Öresund, Malmö, Sweden, 7 Institute Pronatal, Prague, Czech Republique, 8 AVA-klinikka, Tampere, Finland and 9 Zentrum für Sterilitätsbetreuung, Innsbruck, Austria

10 To whom correspondence should be addressed. e-mail: j.brosens{at}imperial.ac.uk

BACKGROUND: The success of IVF treatment is dependent upon embryo quality and coordinated growth and differentiation of the endometrium. Aromatase P450 expression in the human endometrium is thought to be restricted to women with proliferative reproductive tract disorders such as endometriosis, leiomyomas and adenomyosis. METHODS: To determine whether endometrial aromatase P450 mRNA expression is prognostic of IVF outcome, we quantified transcript levels in biopsy specimens from a cohort of subfertile patients awaiting IVF treatment using real-time quantitative PCR. RESULTS: Aromatase P450 transcripts were detected in all endometria examined, although the levels varied considerably between samples, ranging from 0.22 to 486.6 arbitrary units (a.u.). The clinical pregnancy rate in women with high endometrial aromatase P450 mRNA levels (≥8.3 a.u.; n = 21) was 9.5% compared with 30.1% in those patients with low expression levels (<8.3 a.u.; n = 101) (P < 0.05). The cycle day of the endometrial biopsy, cause of infertility, age, parity, number of oocytes collected and number of embryos transferred did not differ between patients with high versus low endometrial aromatase P450 mRNA levels (P > 0.1). CONCLUSIONS: Our results indicate that endometrial P450 mRNA levels can identify women at increased risk of IVF treatment failure.

Key words: aromatase/endometrium/IVF/mRNA/pregnancy outcome


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum ReprodHome page
S. Colette, J.C. Lousse, S. Defrere, M. Curaba, J.F. Heilier, A. Van Langendonckt, M. Mestdagt, J.M. Foidart, E. Loumaye, and J. Donnez
Absence of aromatase protein and mRNA expression in endometriosis
Hum. Reprod., September 1, 2009; 24(9): 2133 - 2141.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A. Purohit, L. Fusi, J. Brosens, L.W.L. Woo, B.V.L. Potter, and M.J. Reed
Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: a potential new therapy
Hum. Reprod., February 1, 2008; 23(2): 290 - 297.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
E.J. Margalioth, A. Ben-Chetrit, M. Gal, and T. Eldar-Geva
Investigation and treatment of repeated implantation failure following IVF-ET
Hum. Reprod., December 1, 2006; 21(12): 3036 - 3043.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
P. Kuivasaari, M. Hippelainen, M. Anttila, and S. Heinonen
Effect of endometriosis on IVF/ICSI outcome: stage III/IV endometriosis worsens cumulative pregnancy and live-born rates
Hum. Reprod., November 1, 2005; 20(11): 3130 - 3135.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
R. Homburg
Clomiphene citrate--end of an era? a mini-review
Hum. Reprod., August 1, 2005; 20(8): 2043 - 2051.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M.M. Wolfler, F. Nagele, A. Kolbus, S. Seidl, B. Schneider, J.C. Huber, and W. Tschugguel
A predictive model for endometriosis
Hum. Reprod., June 1, 2005; 20(6): 1702 - 1708.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.